Results
1 -
10 of
35
(Click
here to explore results)
Drug Discovery for Psychiatric Disorders, CHAPTER 8 Beyond SSRIs: Second-generation Reuptake Inhibitors for the Treatment of Depression . Peter T. Gallagher
, 2012
, Pages 184-225
Biocatalysis: An Industrial Perspective, CHAPTER 5 Bristol-Myers Squibb: Preparation of Chiral Intermediates for the Development of Drugs and APIs . Ramesh N. Patel
, 2018
, Pages 125-167
Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 13 5‐HT1A Receptors as a Therapeutic Target for Parkinson’s Disease . Saki Shimizu, Yukihiro Ohno
, 2013
, Pages 308-326
Electrochemical Detection in HPLC: Analysis of Drugs and Poisons, Applications of HPLC-ED in the analysis of drugs . Roger M. Smith, Robert J. Flanagan, David Perrett, Robin Whelpton
, 2005
, Pages 104-210
Designing Multi-Target Drugs, Chapter 16 Discovery of the Anti-Psychotic Drug, Ziprasidone . John A. Lowe, III
, 2012
, Pages 263-269
Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and other Xenobiotics, Chapter 11 The CYP3 Family . David J. Greenblatt, Ping He, Lisa L. von Moltke, Michael H. Court
, 2008
, Pages 354-383
New Horizons in Predictive Toxicology: Current Status and Application, Chapter 21 Metabolism-Based Toxicology Prediction . F. Peter Guengerich
, 2012
, Pages 542-562
The Handbook of Medicinal Chemistry: Principles and Practice, CHAPTER 15 Discovery Toxicology In Lead Optimisation . Simone Braggio, Mauro Corsi, Aldo Feriani, Stefano Fontana, Luciana Marocchio, Caterina Virginio
, 2015
, Pages 364-412
Catalytic Aerobic Oxidations, CHAPTER 8 Aerobic Oxidation Reactions in the Fine Chemicals and Pharmaceutical Industries . Vanessa R. Landaeta, Rafael E. Rodríguez-Lugo
, 2020
, Pages 252-290
Nutraceuticals and Human Health: The Food-to-supplement Paradigm, Chapter 12 Clinically-relevant Herb–Drug Interactions: Current Status and Practical Considerations . Bill Gurley
, 2020
, Pages 204-231